Literature DB >> 10898160

Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrins.

S Rudaz1, C Stella, A E Balant-Gorgia, S Fanali, J L Veuthey.   

Abstract

Capillary electrophoresis (CE) was used for the simultaneous chiral determination of venlafaxine (Vx), a new antidepressant drug and its main active metabolite. O-desmethyl venlafaxine (ODV). Among the charged cyclodextrins (CD) tested, phosphated gamma-CD was the most appropriate. Resolution of Vx and ODV was obtained with 50 mM phosphate buffer (pH 2.5) containing 20 mg/ml of phosphated gamma-CD. After optimisation of the method (including robustness), validation was carried out. Vx and ODV concentrations, as well as the enantiomeric ratio, were investigated in clinical samples. Chiral determination of Vx and ODV was performed after a simple liquid-liquid extraction (LLE). In the tested concentration range (25-500 ng/ml), coefficients of correlation were superior to 0.996. Within-day and between-day accuracy and precision were determined at three different concentrations for each enantiomer. Analyses of clinical samples (n = 16) exhibited non-racemic ratios for Vx and ODV, which suggests a stereoselective metabolism in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898160     DOI: 10.1016/s0731-7085(00)00280-6

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Development of an enantioselective assay for simultaneous separation of venlafaxine and O-desmethylvenlafaxine by micellar electrokinetic chromatography-tandem mass spectrometry: Application to the analysis of drug-drug interaction.

Authors:  Yijin Liu; Michael Jann; Chad Vandenberg; Chin B Eap; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2015-10-03       Impact factor: 4.759

2.  Time course of clinical response to venlafaxine: relevance of plasma level and chirality.

Authors:  Marianne Gex-Fabry; Androniki E Balant-Gorgia; Luc P Balant; Serge Rudaz; Jean-Luc Veuthey; Gilles Bertschy
Journal:  Eur J Clin Pharmacol       Date:  2003-12-24       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.